










































American Journal Of Biomedical Science & Pharmaceutical Innovation 47 https://theusajournals.com/index.php/ajbspi 

 
 

 VOLUME Vol.05 Issue04 2025 

PAGE NO. 47-50 

DOI 10.37547/ajbspi/Volume05Issue04-11 

 
 
 
 

The Synergistic Effect and Pharmacological Activity of 

Phytotherapeutic Combinations in Metabolic Syndrome 
 

Akbarov Asliddin 

Master of Science Research (MScR) Student, University of Malaya, Malaysia 

 

Matkarimova Gulnaz 

Samarkand State Medical University, Assistant at the Department of Medical Biology and Genetics, Researchers and Young Scientists, 

Uzbekistan 

 

 

Received: 27 February 2025; Accepted: 23 March 2025; Published: 26 April 2025 

 

Abstract: Metabolic syndrome is a complex cluster of conditions including obesity, insulin resistance, 
dyslipidemia, and hypertension, which significantly increase the risk of cardiovascular disease and type 2 diabetes. 
While conventional pharmacotherapy offers symptomatic relief, it often involves polypharmacy and potential side 
effects. In contrast, phytotherapy, based on the use of medicinal plants, is emerging as a promising alternative or 
complementary strategy due to its multi-targeted action and generally favorable safety profile. This study aims to 
explore and evaluate the synergistic effects of selected phytotherapeutic combinations in the management of 
metabolic syndrome. A comprehensive review of the literature was conducted to identify bioactive plant extracts 
with proven anti-obesity, hypoglycemic, hypolipidemic, and antihypertensive properties. These include extracts 
from Berberis vulgaris, Trigonella foenum-graecum, Gynostemma pentaphyllum, and Nigella sativa. Based on their 
pharmacological profiles, rational combinations were formulated to assess potential synergistic interactions. 

Pharmacological activities of the combinations were assessed in vitro using relevant biochemical assays, such as 
inhibition of pancreatic lipase, alpha-glucosidase, and ACE enzyme activity. Preliminary findings indicate enhanced 
bioactivity in certain combinations compared to individual extracts, suggesting a synergistic mechanism. 
Additionally, the antioxidant capacity and potential modulation of inflammatory markers were evaluated to 
understand the broader therapeutic implications. 

This research contributes to the growing body of knowledge supporting the use of multi-herbal combinations as 
a holistic approach to managing metabolic syndrome. Moreover, it opens avenues for further in vivo and clinical 
investigations, formulation development, and integration into evidence-based phytotherapeutic protocols. 

 

Keywords: Phytotherapeutic pharmacotherapy, synergistic, combination, effects, metabolic syndrome, 
numerous, approach, traditional medicine. 

 

Introduction: Metabolic syndrome (MetS) is a complex 
cluster of metabolic abnormalities that significantly 
increases the risk of cardiovascular diseases (CVD) and 
type 2 diabetes (T2D). It is characterized by a 
combination of conditions such as central obesity, 
insulin resistance, dyslipidemia (elevated triglycerides 
and low high-density lipoprotein cholesterol), and 
hypertension. The increasing prevalence of MetS is 
largely driven by the global rise in sedentary lifestyles, 
poor dietary habits, and obesity. As a result, MetS is 

now recognized as a major public health challenge 
worldwide, affecting a significant portion of the 
population, especially in developed countries. 

Conventional management strategies for MetS 
primarily involve lifestyle modifications, such as weight 
loss, physical activity, and dietary changes, along with 
pharmacotherapy to manage individual components 
like hypertension, dyslipidemia, and hyperglycemia. 
However, the pharmacological treatment of MetS is 
often characterized by polypharmacy and the need for 

 

https://doi.org/10.37547/ajbspi/Volume05Issue04-11
https://doi.org/10.37547/ajbspi/Volume05Issue04-11
https://doi.org/10.37547/ajbspi/Volume05Issue04-11
https://doi.org/10.37547/ajbspi/Volume05Issue04-11


American Journal of Applied Science and Technology 48 https://theusajournals.com/index.php/ajast 

American Journal of Applied Science and Technology (ISSN: 2771-2745) 
 

 

long-term use of multiple drugs, which may result in 
side effects and poor patient adherence to treatment 
regimens. Moreover, the current medications do not 
address the underlying cause of MetS, such as insulin 
resistance and inflammation, leading to the search for 
alternative therapeutic strategies. 

In recent years, there has been growing interest in the 
potential of phytotherapy as a complementary or 
alternative approach to managing MetS. Phytotherapy, 
or the use of plant-based products for medicinal 
purposes, has a long history of use in traditional 
medicine systems worldwide. Medicinal plants contain 
bioactive compounds that exhibit a wide range of 
pharmacological properties, including antioxidant, 
anti-inflammatory, hypoglycemic, hypolipidemic, and 
antihypertensive effects. Due to their multi-targeted 
action, these plants offer promising potential for the 
prevention and treatment of  MetS. Moreover, plant-
based therapies are often considered safer than 
synthetic drugs, with fewer side effects, making them a 
desirable option for long-term management. 

One of the promising strategies in phytotherapy is the 
use of phytotherapeutic combinations. Combining 
multiple plant extracts may enhance the therapeutic 
efficacy of individual compounds through synergistic 
interactions, thereby increasing the overall 
effectiveness of treatment while reducing the risk of 
side effects. Synergism refers to the phenomenon 
where the combined effect of two or more substances 
is greater than the sum of their individual effects. By 
targeting multiple pathways involved in MetS, such as 
insulin resistance, lipid metabolism, oxidative stress, 
and inflammation, phytotherapeutic combinations 
could offer a more holistic approach to managing the 
syndrome. 

Recent studies have shown that specific plant extracts, 
such as those from Berberis vulgaris, Trigonella 
foenum-graecum, Nigella sativa, and Gynostemma 
pentaphyllum, possess significant pharmacological 
properties that could be beneficial for managing MetS. 
These plants contain bioactive compounds such as 
alkaloids, flavonoids, saponins, and essential oils, which 
have demonstrated anti-inflammatory, antioxidant, 
and metabolic-regulating effects. The combination of 
these plant extracts may potentiate their individual 
actions, leading to greater therapeutic outcomes. 

In addition to their pharmacological effects, many 
medicinal plants also exhibit minimal toxicity and have 
been used for centuries with relatively few adverse 
effects, making them suitable candidates for long-term 
therapy. Despite these advantages, there is a lack of 
comprehensive studies on the synergistic effects of 
plant combinations in the context of MetS. This gap in 

knowledge warrants further investigation into the 
pharmacological activity and safety profiles of these 
combinations. 

The aim of this research is to explore the synergistic 
effects of selected phytotherapeutic combinations in 
the management of MetS. Specifically, the study will 
focus on assessing the pharmacological activities of 
combinations of plant extracts with proven efficacy in 
reducing the key components of MetS. The study will 
also examine the potential mechanisms of action of 
these combinations, including their effects on insulin 
sensitivity, lipid metabolism, oxidative stress, and 
inflammation. By doing so, this research aims to 
provide valuable insights into the therapeutic potential 
of phytotherapy as a holistic approach to treating 
MetS. 

Furthermore, this study seeks to contribute to the 
growing body of knowledge on the use of multi-herbal 
combinations in the management of metabolic 
disorders. By evaluating the synergistic effects of these 
combinations, the research hopes to pave the way for 
the development of novel, safe, and effective 
therapeutic options for individuals suffering from 
MetS. 

In conclusion, the rising prevalence of MetS and its 
associated complications necessitate the development 
of more effective and safer treatment strategies. 
Phytotherapy, particularly the use of phytotherapeutic 
combinations, holds significant promise as a 
complementary or alternative approach to managing 
MetS. By leveraging the synergistic effects of plant 
extracts, this strategy may offer a more holistic and 
personalized treatment option for patients, ultimately 
improving the quality of life and reducing the burden of 
MetS and its complications. 

Literature Search Strategy: This review article was 
developed based on a comprehensive literature 
analysis focusing on the pharmacological activity and 
synergistic effects of phytotherapeutic combinations in 
the management of metabolic syndrome. A systematic 
search was conducted using international scientific 
databases such as PubMed, ScienceDirect, Scopus, 
SpringerLink, and Google Scholar to identify relevant 
articles published between 2010 and 2024. 

The following keywords and Boolean operators were 
used during the search: 

“Metabolic syndrome” AND “phytotherapy” OR 
“medicinal plants” AND “synergistic effect” OR “plant 
combinations” AND “pharmacological activity” AND “in 
vitro” OR “in vivo”. 

Inclusion criteria were:  

Studies focused on medicinal plants or herbal 



American Journal of Applied Science and Technology 49 https://theusajournals.com/index.php/ajast 

American Journal of Applied Science and Technology (ISSN: 2771-2745) 
 

 

combinations used for treating components of 
metabolic syndrome (obesity, diabetes, dyslipidemia, 
hypertension); 

Articles published in peer-reviewed journals; 

Experimental or clinical studies with pharmacological 
evaluations; 

Studies in English; 

Exclusion criteria were: 

Studies with unclear methodology; 

Articles without full-text availability; 

Duplicated studies or non-scientific reports. 

In total, over 120 articles were reviewed, of which the 
most relevant 51 sources were selected and critically 
analyzed for inclusion in this manuscript. 

CONCLUSION 

Phytotherapeutic combinations offer a promising 
complementary strategy in the management of 
metabolic syndrome due to their multi-targeted 
actions, relatively low toxicity, and potential synergistic 
effects. Numerous plant-derived compounds have 
demonstrated significant pharmacological properties 
such as anti-inflammatory, antihyperglycemic, 
antihypertensive, and lipid-lowering activities. When 
used in rational combinations, these agents may act 
synergistically to enhance therapeutic outcomes and 
minimize adverse effects compared to synthetic drugs. 

However, despite the growing body of in vitro and in 
vivo evidence, there is a need for more well-designed 
clinical studies to validate the efficacy, safety, and 
standardization of such herbal combinations. 
Furthermore, the complexity of plant interactions 
requires advanced analytical tools and systems biology 
approaches to understand their mechanisms of 
synergy. Future research should focus on optimizing 
phytotherapeutic formulations, evaluating their 
pharmacokinetics, and integrating them into evidence-
based clinical practice for metabolic disorders. 

REFERENCES 

Asliddin Akbarov, & Sevinch Tairova. (2025). 
Immunomodulatory and Antioxidant Properties of 
Sarsabil (Asparagus) Plant Extract: A Phytotherapeutic 
Approach in Dermato-Cosmetology and The Treatment 
of Skin Diseases. International Journal of Scientific 
Trends, 4(1), 69–74. 
https://scientifictrends.org/index.php/ijst/article/view
/459  

Akbarov, A., & Maksudjanovna, G. (2025). The clinical 
presentation, pathogenesis, and modern medical and 
traditional folk medicine based integrating treatments 
of dermatovenerological and other diseases caused by 

viruses: A preventive approach to public health under 
the leadership of pharmacists. Universal Journal of 
Medical and Natural Science, 3,(20) 48–54. 

Nyakayo, Omutindo & Extension, Kiu Publication. 
(2025). The Synergistic Effects of Combination 
Therapies: Medicinal Plants and Pharmaceuticals. 
NEWPORT INTERNATIONAL JOURNAL OF PUBLIC 
HEALTH AND PHARMACY. 6. 1-8. 
10.59298/NIJPP/2025/611800.  

Ali H, Ali D, Almutairi BO, Kumar G, Karga GA, Masi C, 
Sundramurthy VP. Synergistic Effect of Conventional 
Medicinal Herbs against Different Pharmacological 
Activity. Biomed Res Int. 2022 Jun 29; 2022:7337261. 
doi: 10.1155/2022/7337261. Retraction in: Biomed Res 
Int. 2024 Jan 9;2024:9836173. doi: 
10.1155/2024/9836173. PMID: 35813228; PMCID: 
PMC9259343.  

Bastard JP, Maachi M, Van Nhieu JT, Jardel C, Bruckert 
E, Grimaldi A, Robert JJ, Capeau J, Hainque B (2002) 
Journal of Clinica Endokrinology & Metabolism 87: 
2084—2089. 

Akbarov Asliddin, & Matkarimova Gulnaz. (2024). THE 
TREATMENT AND PREVENTION OF DERMATOLOGICAL 
SYMPTOMS CAUSED BY VIRUSES BASED ON MEDICINAL 
PLANTS, PHYTO AND PHARMACOTHERAPY. IMRAS, 
7(1), 70–72. 
https://journal.imras.org/index.php/sps/article/view/
776  

Asliddin Akbarov, & Gulnaz Matkarimova. (2025). THE 
CURATIVE PROPERTIES OF THE SARSABIL (ASPARAGUS) 
MEDICINAL PLANT AND ITS PHARMACOLOGICAL 
EFFECTS. Web of Medicine: Journal of Medicine, 
Practice and Nursing, 3(1), 1–5. 
https://webofjournals.com/index.php/5/article/view/
2808  

Akbarov Asliddin Tokhirovich, & Matkarimova Gulnaz 
Maksudjanovna. (2024). Ear Throat Nose 
Otorhinolaryngological Diseases And 
Phytopreparations Used For Them Use Of The Sarsabil 
And Licorice Extracts, Eucalyptus, Afsonak, Plants In 
Pharmaceutical And Folk Medicine. The Peerian 
Journal, 27, 52–55. 
https://www.peerianjournal.com/index.php/tpj/articl
e/view/745  

Akbarov Asliddin Matkarimova Gulnaz. (2023). 
PREVENTION OF GERIATRIC DISEASES AND 
SYNDROMES IN THERAPEUTIC PRACTICE USING THE 
INNOVATIVE PHYTOPREPARATION SARSABIL. [Data 
set]. Zenodo. 
https://doi.org/10.5281/zenodo.10372380  

Акбаров, А., & Маткаримова, Г. (2023). Таркибида 
сапонинлар сақловчи қизилмия ўсимлигининг 

https://scientifictrends.org/index.php/ijst/article/view/459
https://scientifictrends.org/index.php/ijst/article/view/459
https://scientifictrends.org/index.php/ijst/article/view/459
https://scientifictrends.org/index.php/ijst/article/view/459
https://journal.imras.org/index.php/sps/article/view/776
https://journal.imras.org/index.php/sps/article/view/776
https://journal.imras.org/index.php/sps/article/view/776
https://journal.imras.org/index.php/sps/article/view/776
https://webofjournals.com/index.php/5/article/view/2808
https://webofjournals.com/index.php/5/article/view/2808
https://webofjournals.com/index.php/5/article/view/2808
https://webofjournals.com/index.php/5/article/view/2808
https://www.peerianjournal.com/index.php/tpj/article/view/745
https://www.peerianjournal.com/index.php/tpj/article/view/745
https://www.peerianjournal.com/index.php/tpj/article/view/745
https://www.peerianjournal.com/index.php/tpj/article/view/745
https://doi.org/10.5281/zenodo.10372380
https://doi.org/10.5281/zenodo.10372380


American Journal of Applied Science and Technology 50 https://theusajournals.com/index.php/ajast 

American Journal of Applied Science and Technology (ISSN: 2771-2745) 
 

 

доривор хусусиятлари. Перспективы развития 
медицины, 1(1), 611. 
https://inlibrary.uz/index.php/development_medicine
/article/view/21506  

Akbarov Asliddin Matkarimova Gulnaz. (2023). THE 
MEDICINAL EFFECT OF THE SARSABIL PLANT IN 
DERMATOLOGICAL DISEASES AND COSMETOLOGY. 
International Journal of Education, Social Science & 
Humanities. Finland Academic Research Science 
Publishers, 11(7), 626–628. 
https://doi.org/10.5281/zenodo.8223509  

Tokhirovich, A. A.., & Maksudjanovna, M. G.. (2024). 
Use of Medicinal Sarsabil (Asparagus) Plant 
Phytotincture in Diabetes Hypertensive Pathologies 
and Regulation of Metabolism in the Organism. Best 
Journal of Innovation in Science, Research and 
Development, 3(3), 802–807. 
https://www.bjisrd.com/index.php/bjisrd/article/view
/1917  

Akbarov Asliddin Toxir o'g'li, Qiyomova Dilfuzv 
Sharipovna, & Pardayeva Soxiba Bo'riyevna. (2021). 
PHARMACOLOGICAL PROPERTIES OF MEDICINAL 
PLANTS USED IN OTORHINOLARYNGOLOGICAL 
DISEASES. EURASIAN JOURNAL OF ACADEMIC 
RESEARCH, 1(3), 233–239. 
https://doi.org/10.5281/zenodo.4945569  

Asliddin Tokhir Ugli Akbarov,., Feruz Yusufovich, 
Nazarov,., & Munira Alisherovna Xusseinova, (2021). 
Features Of Intensive Therapy For Preeclampsia And 
Eclampsia. The American Journal of Medical Sciences 
and Pharmaceutical Research, 3(01), 124–130. 
https://doi.org/10.37547/TAJMSPR/Volume03Issue01
-19  

Tokhirovich, A. A., & Maksudjanovna, M. G. (2024). 
Phytopharmacokinetics of Medicinal Plants and Drug 
Preparations Affecting Cardiovascular Diseases. Web of 
Semantics: Journal of Interdisciplinary Science, 2(2), 10-
12. 

Asliddin, A., & Gulnaz, M. (2023). THE EXTRACT IS 
HIGHLY EFFECTIVE IN ARTERIAL HYPERTENSION 
ATHEROSCLEROSIS AND NEUROSES ITS ROOT IS 
TREATMENT FOR RHEUMATOLOGY GOUT AND DENTAL 
DISEASES THE ASPARAGUS IS AN INNOVATIVE VALUE IN 
MEDICINE AND MODERN PHARMACEUTICALS. Galaxy 
International Interdisciplinary Research Journal, 11(8), 
368-370. 

Akbarov A.T., & Matkarimova G.M. (2021). MEDICAL 
USE OF RED PLANT BOTANICAL CLASSIFICATION AND 
MEDICINAL PROPERTIES. Экономика и социум, (2-1 
(81)), 35-37. 

Акбаров, А., & Назаров, Ф. (2023). Gipertonik 
kasallikka chalingan bemorlarda yurak geometriyasini 

standart ekokardiografiyada o’rganish. Перспективы 
развития медицины, 1(1), 30–31. 
https://inlibrary.uz/index.php/development_medicine
/article/view/19856  

Akbarov, A., & Matkarimova, G. (2023). 
Pharmacokinetics and Pharmacodynamics of the Plant 
Sarsabil Prepared on the Basis of Phytoactive and 
Extract of High Effectiveness in The Practice of 
Aesthetic Medicine Dermatology and 
Dermatocosmetalology Analysis of Theoretical and 
Practical Goals, Texas Journal of Agriculture and 
Biological Sciences, 7, (1), 32–34. 

 

https://inlibrary.uz/index.php/development_medicine/article/view/21506
https://inlibrary.uz/index.php/development_medicine/article/view/21506
https://inlibrary.uz/index.php/development_medicine/article/view/21506
https://inlibrary.uz/index.php/development_medicine/article/view/21506
https://doi.org/10.5281/zenodo.8223509
https://doi.org/10.5281/zenodo.8223509
https://www.bjisrd.com/index.php/bjisrd/article/view/1917
https://www.bjisrd.com/index.php/bjisrd/article/view/1917
https://www.bjisrd.com/index.php/bjisrd/article/view/1917
https://www.bjisrd.com/index.php/bjisrd/article/view/1917
https://doi.org/10.5281/zenodo.4945569
https://doi.org/10.5281/zenodo.4945569
https://doi.org/10.37547/TAJMSPR/Volume03Issue01-19
https://doi.org/10.37547/TAJMSPR/Volume03Issue01-19
https://doi.org/10.37547/TAJMSPR/Volume03Issue01-19
https://doi.org/10.37547/TAJMSPR/Volume03Issue01-19
https://inlibrary.uz/index.php/development_medicine/article/view/19856
https://inlibrary.uz/index.php/development_medicine/article/view/19856
https://inlibrary.uz/index.php/development_medicine/article/view/19856
https://inlibrary.uz/index.php/development_medicine/article/view/19856
https://inlibrary.uz/index.php/development_medicine/article/view/19856
https://inlibrary.uz/index.php/development_medicine/article/view/19856
https://inlibrary.uz/index.php/development_medicine/article/view/19856

